Full Presentation attached to announcement, reading now
PRESENTATION
FOR IMMEDIATE RELEASE
18 MARCH 2010
Pharmaceutical and Healthcare group, Stirling Products Limited
(ASX:STI) is pleased to advise that following the settlement of its
4310 Sq Metre high-tech pharmaceutical production facility in Cape
Breton, Canada and its highly successful launch of Stirling Health
at the Australian Pharmacy Professional Conference and Trade
Exhibition (APP2010) last weekend, the Company will today
commence a broker roadshow.
The Presentation forms part of this Company Announcement and
follows.
In conjunction with the release of this Presentation the Company
also advises of its new websites launched today which now better
present the Company following the completion of the Companys
strategic acquisitions and product positioning.
The Companys major commercialisation drive is now conducted
through five distinct business units. Sales and Manufacturing
Divisions are a prime focus as will be the ongoing commercialisation
works directed towards realising the three distinct blockbuster
product opportunities that the Company has secured.
For further information see www.stirlingproducts.net
www.stirlinghealth.com.au or contact:
Peter Boonen
Managing Director
Stirling Products Limited
Ph: +61 2 9299 9270
E: [email protected]
For all Investor Relations inquiries please contact:
James Moses
Mandate Corporate
Ph: +61 420 991 574
E: [email protected]
Add to My Watchlist
What is My Watchlist?